by 
Nausea medications are used to treat nausea and vomiting related conditions. Common nausea medications includes antiemetics and antihistamines which are available as oral tablets, injectables and as transdermal patches. Nausea is commonly associated with conditions like motion sickness, gastrointestinal illnesses, after surgeries, during chemotherapy and pregnancies. Rising prevalence of conditions causing nausea and vomiting has resulted in increased demand for antiemetic drugs globally. For instance, according to studies nearly 30-80% of cancer patients experience chemotherapy-induced nausea and vomiting which significantly impacts their quality of life. Additionally, post-surgical nausea and vomiting is also common occurring in nearly 30% of the surgical cases.
The global nausea medicine market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The nausea medicine market is driven by rising burden of nausea and vomiting related conditions. As per the heading, nausea is commonly associated with conditions like motion sickness, gastrointestinal illnesses, after surgeries, during chemotherapy and pregnancies. For instance, chemotherapy-induced nausea and vomiting (CINV) affects nearly 70% of cancer patients undergoing chemotherapy. Additionally, around 30% patients experience post-operative nausea and vomiting after general anesthesia. Growing prevalence of chronic conditions requiring nausea medications will continue to drive the market during the forecast period.
Segment Analysis
The nausea medicine market is dominated by the oral segment, which accounts for more than 65% share of the total market. Oral medications are the most preferred choice for treating nausea as they are convenient, easy to administer, and provide quick relief. Pharmaceutical companies have been focused on developing advanced oral formulations such as orally disintegrating tablets and capsules to minimize nausea episodes at the earliest.
PEST Analysis
Political: Government regulations around drug pricing and approval processes influence the demand and commercialization of new nausea drugs. Strict laws to prevent drug abuse can also impact market growth.
Economic: Changes in healthcare expenditure, per capita income, and insurance coverage impact the affordability of prescription drugs, thereby affecting market revenues. The growing economy favors greater access to quality healthcare including anti-emetics.
Social: Increasing prevalence of lifestyle disorders, cancer, gastrointestinal ailments are key factors leading to rising incidences of nausea worldwide. Growing awareness about available treatment options is encouraging people to seek timely medical help.
Technological: Continuous R&D in drug delivery systems has led to development of novel formulations such as sublingual tablets and injectables to provide fast relief from nausea and vomiting. Nanotechnology-based formulations can help enhance bioavailability.
Key Takeaways
The global nausea medicine market is expected to witness high growth over the forecast period supported by the increasing prevalence of diseases causing nausea such as cancer, gastrointestinal disorders, and side-effects of antibiotic and anesthetic drugs. The global nausea medicine market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030.
Regional analysis- North America dominates the nausea medicine market owing to the rising healthcare spending, rapid adoption of new drug therapies, and presence of major market players in the region. Asia Pacific is anticipated to witness the fastest growth during the forecast period with expanding healthcare infrastructure and patient awareness in countries like China and India.
Key players operating in the nausea medicine market are GlaxoSmithKline plc., Pfizer Inc., Novartis International AG, Sanofi S.A., Merck & Co., Inc., Johnson & Johnson, Bayer AG, Takeda Pharmaceutical Company Limited, AstraZeneca plc., and Eli Lilly and Company. Key players are focused on developing novel formulations to achieve quicker relief from nausea and vomiting side effects.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
